The North America Spine Bone Stimulators Market would witness market growth of 3.7% CAGR during the forecast period (2022-2028).
A bone growth stimulator (BGS) helps the bone mend faster by sending more power to the healing bone surface via pulsed electromagnetic or ultrasonic waves. Only external bone growth stimulators are used by the Orthopedic doctors at OSC. Internal BGS units are costly, require a second operation to remove the unit's battery and wires from the body, and are implanted at the moment of surgery.
External BGS can be used on practically any part of the body if there has been a fracture or surgery. They come in two forms devices that link to electrodes that supply electricity to the skin over the non-healing bone and braces or belts that can be worn or used to recline a patient when sitting. To be effective, the BGS device must be used for multiple hours each day for three to nine months, and patients’ satisfaction is needed to attain the greatest results. The units are lightweight, comfy, and secure. Unlike TENs units, they do not require any modifications. The electric current is imperceptible to the patient and produces no discomfort.
The rise in spine surgery usage in the United States has been very well reported. Technological developments, elderly patients anticipating greater levels of function, and funding mechanisms that favor advanced fusion surgery have all assisted the growth of the spine bone stimulator market in the United States. According to the 2019 SCI Datasheet from the National Spinal Cord Injury Statistical Center, the annual incidence of spinal cord injury (SCI) in the United States is roughly 54 cases per one million people, or around 17,810 new SCI-related cases each year. There were millions of people with spinal cord injuries in the United States in 2019.
Furthermore, according to the American Chiropractic Association, nearly 31 million people in the United States suffer from lower back pain at some point in their lives in 2018. Obesity, an inactive lifestyle, athletics, and accident-related ailments all contribute to the rise in spinal non-fusion treatments. Furthermore, posterior operations have gained in popularity in recent years and are expected to expand faster in the future than anterior treatments. As a result, as the number of treatments performed in the country grows, so does the number of spine bone stimulators utilize.
The US market dominated the North America Spine Bone Stimulators Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $170.1 million by 2028. The Canada market is anticipated to grow at a CAGR of 6% during (2022 - 2028). Additionally, The Mexico market would display a CAGR of 5.1% during (2022 - 2028).
Based on Device Type, the market is segmented into Non-Invasive and Invasive. Based on End User, the market is segmented into Hospitals, Specialty Clinics, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Spine Bone Stimulators Market is Estimated to reach $626.2 Million by 2028, at a CAGR of 4.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include DJO Global, Inc. (Enovis), Zimmer Biomet, Orthofix Medical Inc., Elizur Corporation, Ossatec Benelux BV, IGEA S.p.A., ManaMed Inc., Theragen, Inc., Intelligent Implants, and Orchid Medical, Inc
By Device Type
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
